...
机译:
Krankenhaus Maria Hilf, Urol Klin, D-47805 Krefeld, Germany;
Hannover Med Sch, Urol Klin, Hannover, Germany;
testicular cancer; laparoscopy; primary retroperitoneal lymph node dissection; residual tumor resection; GERM-CELL TUMORS; PROSPECTIVE MULTICENTER TRIAL; RISK-ADAPTED TREATMENT; TESTIS-CANCER; PROGNOSTIC-FACTORS; LYMPHADENECTOMY; CHEMOTHERAPY; CARCINOMA; EXPERIENCE; MANAGEMENT;
机译:Re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor—N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?
机译:Nanchong Central Hospital Reports Findings in Testicular Cancer (The role of robotic retroperitoneal lymph node dissection in testicular cancer: a systematic review and meta-analysis)
机译:Robotic-assisted retroperitoneal lymph node dissection for testicular cancer
机译:Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and s-1 (DCs therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes